Page semi-protected

Ulf Mark Schneider

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Ulf Mark Schneider
Ulf Mark Schneider.jpg
Schneider in 2019
Born (1965-09-09) 9 September 1965 (age 55)
Neuwied, Germany
NationalityGerman
CitizenshipGerman and American
EducationUniversity of St. Gallen
Harvard Business School
TitleCEO, Nestlé
TermJanuary 2017-
PredecessorPaul Bulcke

Ulf Mark Schneider (born 9 September 1965) is a German/American businessman, and the CEO of Nestlé. He is the former CEO of Fresenius, a €28 billion global healthcare group.[1]

Early life

Schneider was born and raised in Neuwied, Germany, he became a U.S. citizen in 2003.[2] He holds a doctorate in economics from the University of St. Gallen, Switzerland, and an MBA from Harvard Business School.[3]

Career

Schneider was group finance director for Gehe UK plc., a pharmaceutical wholesale and retail distributor, in Coventry, England. Schneider held several senior executive positions starting in 1989 with Gehe's majority shareholder, Franz Haniel & Cie. GmbH, a diversified German industrial company.[4]

Schneider joined Fresenius in November 2001, when he was appointed chief financial officer of Fresenius Medical Care. From May 2003 until June 2016 he served as CEO of the parent company Fresenius. Under Schneider's leadership of Fresenius, the number of employees more than tripled, revenue quadrupled and net income increased twelvefold.[5] While Schneider was CEO, Fresenius also carried out a number of major strategic acquisitions: the private hospital chain HELIOS Kliniken in 2005; US dialysis provider Renal Care Group, in 2006; US pharmaceutical company APP Pharmaceuticals, in 2008; Liberty Dialysis, another major dialysis provider in the US, in 2011; and, in 2014, the purchase of 41 hospitals from Rhön-Klinikum, through which HELIOS became the largest private hospital operator in Germany.[6]

In June 2016, Schneider was appointed CEO of Nestlé SA, replacing Paul Bulcke. He started as CEO in January 2017.[7] Schneider is the first outsider to run Nestlé since 1922.[8] In 2017, Schneider announced the intent to focus capital spending on higher-growth categories of coffee, pet food, baby food and water and added consumer health to the list of priorities.[9] He divested U.S. confections and ice cream businesses in a multibillion-dollar deals[10][11] and led acquisitions of Atrium Health,[12] Blue Bottle Coffee (majority stake),[13] Sweet Earth Foods, Chameleon Cold-Brew,[14] Tails.com,[15] Freshly,[16] and the Starbucks retail brand.

The management challenges of global growth[17] and future strategies in the healthcare and pharmaceutical industries are of particular interest to Schneider.[18][19][20]

Schneider chaired the European advisory board of Harvard Business School until 2016 and served on the board of directors of the American chemical company DuPont from 2014 to 2017.[21]

Personal life

Schneider is known to speak German, English, and French.[22]

References

  1. ^ "Group Overview – Fresenius SE & Co. KGaA". Retrieved 14 July 2018.
  2. ^ "Curriculum vitae" (PDF). nestle.com. Nestle. June 2016. Retrieved 3 February 2020.
  3. ^ "Management Board – Fresenius SE & Co. KGaA". Retrieved 14 July 2018.
  4. ^ Business Week: New Blood Invigorates Dialysis Company
  5. ^ "Fresenius appoints Stephan Sturm as new Chief Executive Officer – Ulf Mark Schneider leaves the company to pursue another opportunity – Fresenius SE & Co. KGaA". Retrieved 14 July 2018.
  6. ^ "History – Fresenius SE & Co. KGaA". Retrieved 14 July 2018.
  7. ^ "Nestle's press release on June 27th, 2016". www.nestle.com. Retrieved 28 June 2016.
  8. ^ Blackstone, Brian; Chaudhuri, Saabira (27 June 2016). "Nestlé Taps Ulf Mark Schneider as Next CEO". Wall Street Journal. ISSN 0099-9660. Retrieved 14 October 2016.
  9. ^ Keidan, Silke Koltrowitz, Maiya (29 June 2017). "Nestle plan hailed as only the start of Schneider's shake-up". Reuters. Retrieved 8 June 2021.
  10. ^ "Let's make a deal: How Nestlé is using M&A and multibillion-dollar divestitures to shape its portfolio". Food Dive. Retrieved 28 May 2021.
  11. ^ Staff, Reuters (13 February 2020). "Factbox: Nestle CEO Schneider's top deals". Reuters. Retrieved 28 May 2021.
  12. ^ "Nestlé to buy vitamin maker Atrium Innovations for $2.3bn". Financial Times. Retrieved 8 June 2021.
  13. ^ "Nestlé acquires a majority stake in Blue Bottle Coffee at a valuation north of $700M". TechCrunch. Retrieved 8 June 2021.
  14. ^ "Nestlé Expands Portfolio with Acquisition of Chameleon Cold Brew". Daily Coffee News by Roast Magazine. 3 November 2017. Retrieved 8 June 2021.
  15. ^ Staff, Reuters (30 April 2018). "Nestle buys majority stake in British dog food group Tails.com". Reuters. Retrieved 8 June 2021.
  16. ^ Staff, Reuters (31 October 2020). "Nestle buys U.S. meal delivery group Freshly". Reuters. Retrieved 8 June 2021.
  17. ^ "Nestlé CEO: We don't have to sacrifice shareholders to fight climate change". Fortune. Retrieved 2 June 2021.
  18. ^ "St. Gallen Symposium 2006". Retrieved 14 July 2018.
  19. ^ Business Week: A Prescription for Saving Big Drugmakers
  20. ^ Harvard Business School case study: Growth and Profitability at Fresenius
  21. ^ "DowDuPont Inc. – DowDuPont Board of Directors". www.dupont.com. Retrieved 14 July 2018.
  22. ^ "Mark Schneider Mark Schneider: Chief Executive Officer". Nestle. Retrieved 10 October 2019.

External links